Design of toxins that can be activated by cell-specific proteases and their potential use in targeted cell killing.
Protein toxins designed to eliminate specific cell types, e.g. disease-associated cells, have mainly made by linking the active domain of the toxin to a protein that only binds to certain cells. A different approach for the construction of toxins capable of killing disease-associated cells is suggested here, based on the knowledge that many of these cells express specific proteases that are not expressed in normal tissue. The construction of toxins that become activated through cleavage by the protease (HIV-1 PR) expressed by the HIV-1 virus is described. These toxins contain a signal for degradation by the N-end rule pathway, which is cleaved off by HIV-1 PR, resulting in increased toxicity. Alternative strategies for the construction of toxins that can be activated by proteases are discussed.
Falnes
P O
PO
Department of Biochemistry, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo. pal.falnes@labmed.uio.no
D000595:Amino Acid Sequence; D000942:Antigens, Bacterial; D001427:Bacterial Toxins / Q000378:metabolism* / Q000494:pharmacology; D002470:Cell Survival / Q000187:drug effects; D004167:Diphtheria Toxin / Q000378:metabolism* / Q000494:pharmacology; D016333:HIV Protease / Q000494:pharmacology*; D006367:HeLa Cells; D006801:Humans; D008969:Molecular Sequence Data
D000942:Antigens, Bacterial; D001427:Bacterial Toxins; D004167:Diphtheria Toxin; C030325:anthrax toxin; D016333:HIV Protease